German pharmaceutical company Bayer and Yunona Holdings, representing the Ural Pharmaceutical Cluster (UPC) of Russia have entered a memorandum of understanding to manufacture drugs in Russia.
AstraZeneca has invested $200m in a new manufacturing facility in China Medical City, Taizhou, Jiangsu province. The new plant will manufacture both intravenous and oral solid medicines.According to the company, the new plant will help meet the rising demand for its products in China besides extending its availability in urban and rural communities that have limited access to established medicines.
Sun Pharmaceutical has received the US Food and Drug Administration (FDA) acceptance for its manufacturing plant at Cranbury in New Jersey, US.
The global contract manufacturing will reach $64.07bn in 2016, according to a new report by London-based business information company Visiongain. The report, 'Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021,' says that the market will grow with a CAGR of 8.7% between 2010 and 2016, with finished dosage forms manufacturing driving the revenue growth.
Denmark based CMC Biologics and US based Inspiration Biopharmaceuticals have signed a supply agreement to manufacturing bulk IB1001 as a treatment and preventive measure of bleeding in individuals with hemophilia B.
The Medicines & Healthcare products Regulatory Agency (MHRA) of UK has approved India-based Ajanta Pharma's formulation manufacturing plant at Paithan, Aurangabad, India.
Aenova France, a wholly-owned subsidiary Aenova Holding, will lease the whole pharmaceutical manufacturing business and the premises at Saint Quentin-Fallavier, Lyon to SkyePharma Group for an initial period of two years, extendable for a further three years.